Investor Calendar is powered by PrecisionIR, the leading webcaster of official investor relations events, and offers free access to live and archived corporate communications
 
  Home     Calendar     Conferences     Roadshows     Forums     Alerts     Research     Support     Podcast  
  Spherix Inc. (SPEX) www.spherix.com
Spherix Inc.

Enter your email address to receive alerts about this company
Help
June 28, 2012 - 11:30 AM Eastern
LHA Life Sciences & Medical Technologies Virtual Conference


Press Release
      More company presentations from
                   

Spherix Inc.

Dr. Robert A. Lodder
President

Dr. Robert A. Lodder, Spherix Incorporated Board Member since 2005, was elected President in August 2007. He served as a Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Kentucky Medical Center, and holds joint appointments in the Department of Electrical and Computer Engineering and the Division of Analytical Chemistry of the Department of Chemistry at Kentucky. Dr. Lodder received his B.S. degree cum laude in Natural Science in 1981, and his M.S. in Chemistry in 1983 from Xavier University, Cincinnati, Ohio. He received his Ph.D. in Analytical Chemistry in 1988 from Indiana University. He was a founder of InfraReDx, Inc. in 1998 and Prescient Medical, Inc. in 2004. Neither of these companies are public, and they do not engage in business with Spherix. He is not now, nor has he been for the past five years, a director of a public, for-profit company other than Spherix. 		 
 
Information contained in this webcast is current as of the date and time first presented. The use of pop-up blocking or firewall software may prevent you from accessing this webcast. Please temporarily disable any of these products you may have while attempting to access this event.
About The Company
Spherix was launched in 1967 as a scientific research company under the name Biospherics Research. The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is dedicated to developing and licensing/marketing proprietary therapeutic products for treatment of diabetes, metabolic syndrome and atherosclerosis. Biospherics is actively seeking a pharmaceutical partner to continue the development of its Phase 3 compound for the treatment of diabetes, D-tagatose, while exploring new drugs and combinations for treatment of high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke. Spherix’s Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products and industrial chemicals and pesticides. For additional information please visit www.spherix.com.

Market Assistant
Earnings Data
Annual Report
Related Events (times are Eastern) Show times in :
Company NameTicker Date/TimeTypeAlertsAudioPodcastVideoSlidesAnnual
Report
Spherix Inc. SPEX  Jun 28, 2012 
@ 11:30am 		LHA Life Sciences & Medical Technologies Virtual Conference Signup for email alerts about this company's events and news         

Comments or questions? Click Here

Privacy Statement Terms and Conditions


©2000-2013 PrecisionIR. All rights reserved.
   
 

A part of PrecisionIR Group, www.PrecisionIR.com
601 Moorefield Park Drive, Richmond, VA 23236
145 Cannon Street, London, EC4N 5BQ, UK (Registered in England No 2394368)
Strandvägen 7A, 114 56 Stockholm, Sweden